Loading institutional data...
Loading institutional data...
Institutional accumulation: ownership increased +0.94% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 1 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
3/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
Free-cash-flow coverage unavailable. Last year: $4.9B dividends + $1.1B buybacks = $6.0B returned.
3 consecutive years of dividend increases · 69%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 10%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable.
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
How a revenue dollar becomes profit — FY2026
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $148.40B 100.0% | $996.35B 100.0% | $941.17B 100.0% | $868.69B 100.0% | $853.06B 100.0% | $717.29B 100.0% | $509.71B 100.0% | $376.84B 100.0% | $250.27B 100.0% | $158.27B 100.0% |
| Cost of Revenue | $89.32B 60.2% | $598.28B 60.0% | $586.32B 62.3% | $549.70B 63.3% | $539.45B 63.2% | $421.20B 58.7% | $282.37B 55.4% | $206.93B 54.9% | $107.04B 42.8% | $59.48B 37.6% |
| Research & Development | $9.64B 6.5% | $57.15B 5.7% | $52.26B 5.6% | $56.74B 6.5% | $55.47B 6.5% | $57.24B 8.0% | $43.08B 8.5% | $37.44B 9.9% | $22.75B 9.1% | $17.06B 10.8% |
| Selling, General & Admin | $4.80B 3.2% | $44.24B 4.4% | $41.98B 4.5% | $42.18B 4.9% | $31.92B 3.7% | $55.22B 7.7% | $28.20B 5.5% | $24.89B 6.6% | $16.24B 6.5% | $12.24B 7.7% |
| Operating Income | $7.27B 4.9% | $140.91B 14.1% | $113.35B 12.0% | $100.35B 11.6% | $69.64B 8.2% | $89.68B 12.5% | $91.43B 17.9% | $57.08B 15.1% | $69.31B 27.7% | $48.05B 30.4% |
| Interest Expense | $1.42B 1.0% | $9.60B 1.0% | $7.95B 0.8% | $5.92B 0.7% | $4.91B 0.6% | $4.48B 0.6% | $5.18B 1.0% | $5.19B 1.4% | $3.57B 1.4% | $2.67B 1.7% |
| Other Income (Expense), net | $220.0M 0.1% | $3.39B 0.3% | $6.16B 0.7% | $5.82B 0.7% | $10.52B 1.2% | $7.58B 1.1% | $7.44B 1.5% | $221.0M 0.1% | $4.16B 1.7% | $6.09B 3.8% |
| Pretax Income | $18.76B 12.6% | $155.46B 15.6% | $101.60B 10.8% | $89.19B 10.3% | $59.55B 7.0% | $165.58B 23.1% | $166.65B 32.7% | $96.22B 25.5% | $100.40B 40.1% | $60.03B 37.9% |
| Income Tax Expense | $4.36B 2.9% | $35.45B 3.6% | $22.53B 2.4% | $15.55B 1.8% | $26.82B 3.1% | $29.28B 4.1% | $20.56B 4.0% | $16.55B 4.4% | $18.20B 7.3% | $13.78B 8.7% |
| Net Income | $15.02B 10.1% | $130.11B 13.1% | $80.01B 8.5% | $72.78B 8.4% | $62.25B 7.3% | $150.58B 21.0% | $149.43B 29.3% | $87.89B 23.3% | $64.09B 25.6% | $43.67B 27.6% |
| Per Share | ||||||||||
| EPS (Basic) | $0.83 | $6.89 | $3.95 | $3.46 | $2.87 | $6.95 | $7.10 | $4.24 | $3.13 | $2.19 |
| EPS (Diluted) | $0.80 | $6.70 | $3.91 | $3.43 | $2.84 | $6.84 | $6.99 | $4.17 | $3.06 | $2.12 |
| Weighted Avg Shares (Basic) | 18.57B | 18.79B | 20.18B | 20.98B | 21.56B | 21.62B | 21.02B | 20.64B | 20.43B | 19.94B |
| Weighted Avg Shares (Diluted) | 19.23B | 19.32B | 20.36B | 21.11B | 21.79B | 21.98B | 21.35B | 20.99B | 20.88B | 20.58B |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
No current price collected.
No standout strengths flagged.
Nothing notable to watch.
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 54.9 | 55.4 | 58.7 | 63.2 | 63.3 | 62.3 | 60.0 | 60.2 |
| R&D | 9.9 | 8.5 | 8.0 | 6.5 | 6.5 | 5.6 | 5.7 | 6.5 |
| SG&A | 6.6 | 5.5 | 7.7 | 3.7 | 4.9 | 4.5 | 4.4 | 3.2 |
| Operating Income | 15.1 | 17.9 | 12.5 | 8.2 | 11.6 | 12.0 | 14.1 | 4.9 |
| Income Tax | 4.4 | 4.0 | 4.1 | 3.1 | 1.8 | 2.4 | 3.6 | 2.9 |
| Net Income | 23.3 | 29.3 | 21.0 | 7.3 | 8.4 | 8.5 | 13.1 | 10.1 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on BBAAY: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.